A 50-year-old woman should expect a core set of blood tests that screen for cardiovascular risk, metabolic changes, thyroid problems, nutrient deficiencies, and early signs of diabetes. But the list that actually matters at this age goes well beyond the basic panel your doctor might order on autopilot. The perimenopausal and early postmenopausal years bring shifting hormone levels that quietly reshape heart risk, bone density, iron stores, and blood sugar regulation, and specific blood tests can catch those changes before symptoms show up.
The Foundation Panel
Most doctors start with a complete blood count (CBC) and a comprehensive metabolic panel (CMP). The CBC measures your red and white blood cells and platelets, flagging anemia, infections, and blood disorders. The CMP checks kidney function, liver enzymes, electrolytes, and blood sugar. Together, they give a broad snapshot of how your body is functioning. At 50 these are essentially universal, regardless of your health history or symptoms.
On top of that foundation, you should expect a fasting lipid panel. This measures total cholesterol, LDL (“bad”) cholesterol, HDL (“good”) cholesterol, and triglycerides. Cardiovascular risk climbs after menopause because estrogen, which has a protective effect on blood vessels and lipid metabolism, drops. A lipid panel at 50 is not optional screening; it is a baseline that shapes decisions about medication, diet, and follow-up testing for years to come.
Fasting blood glucose and hemoglobin A1c round out the standard metabolic picture. The A1c reflects your average blood sugar over the past two to three months and is the primary screening tool for prediabetes and type 2 diabetes. Insulin resistance becomes more common after menopause. One small study found that a substantial proportion of postmenopausal women showed insulin resistance on standard indices, while none of the premenopausal women in the same study did.1PubMed Central. Analysis of the Degree of Insulin Resistance in Post Menopausal Women by Using Skin Temperature Measurements and Fasting Insulin and Fasting Glucose Levels: A Case Control Study That does not mean every woman crossing 50 is insulin resistant, but it underscores why glucose and A1c belong in every annual workup at this stage.
Thyroid Function Deserves Its Own Attention
Thyroid testing at 50 is more important than many women realize, because thyroid dysfunction and perimenopause can look almost identical. Fatigue, weight gain, mood changes, irregular periods, sleep disruption, and feeling too hot or too cold are symptoms of both. A thyroid-stimulating hormone (TSH) test is the standard first step, and researchers have argued that indications for measuring TSH in perimenopausal women should be kept broad rather than restrictive, precisely because the overlap in symptoms makes clinical diagnosis harder.2PubMed Central. Thyroid Dysfunction in Peri- and Postmenopausal Women – Cumulative Risks
Decreased TSH levels, which point to an overactive thyroid, are found in roughly 8 to 10 percent of women in their fifties and sixties.2PubMed Central. Thyroid Dysfunction in Peri- and Postmenopausal Women – Cumulative Risks That is not a rare condition. And because thyroid dysfunction at this age is less obvious than in younger women, it can quietly accelerate bone loss, raise cardiovascular risk, and worsen mood symptoms that get written off as “just menopause.” If your TSH comes back abnormal, your doctor will typically follow up with free T4 and sometimes free T3 to figure out what exactly the thyroid is doing.
Vitamin D and Calcium
A serum 25-hydroxyvitamin D test measures how much vitamin D is circulating in your blood. This test matters at 50 because bone mineral density starts to drop in the years around menopause, and vitamin D deficiency accelerates that process. Research consistently links low vitamin D and low calcium to higher rates of osteoporosis.3PubMed Central. Vitamin D and Calcium in Osteoporosis, and the Role of Bone Turnover Markers: A Narrative Review of Recent Data from RCTs One study of postmenopausal women with osteoporosis found a high prevalence of vitamin D deficiency and low calcium, and women with lower vitamin D were more likely to have a history of fragility fractures.4European Journal of Cardiovascular Medicine. Evaluation of Serum Vitamin D and Calcium Levels in Postmenopausal Women with Osteoporosis
The connection goes beyond bones. In postmenopausal women with both type 2 diabetes and osteoporosis, those with sufficient vitamin D had significantly higher bone mineral density at every measured site compared to those who were deficient. The same study showed that lower vitamin D tracked with worsening insulin resistance, suggesting that vitamin D status has metabolic consequences that extend past skeletal health.5PubMed Central. Serum 25-hydroxyvitamin D is associated with islet function in postmenopausal women with type 2 diabetes and osteoporosis If your vitamin D is low, supplementation combined with calcium can increase bone mineral density, though vitamin D alone without calcium does not appear to have the same bone-building effect.3PubMed Central. Vitamin D and Calcium in Osteoporosis, and the Role of Bone Turnover Markers: A Narrative Review of Recent Data from RCTs
Most basic metabolic panels include a calcium reading, but a stand-alone vitamin D test is not automatically included in routine bloodwork at many practices. You may need to ask for it specifically, and it is worth doing so.
Iron Studies and the Menopause Shift
Iron is one of those nutrients where the story changes dramatically around menopause. Before menopause, monthly blood loss from periods keeps iron stores relatively low, and iron deficiency is a common concern. After periods stop, that dynamic reverses. Ferritin, transferrin saturation, and hepcidin all increase as women move through perimenopause and into postmenopause, reflecting rising iron stores in the body.6PubMed Central. Changes in Iron Status Biomarkers with Advancing Age According to Sex and Menopause: A Population-Based Study
This shift happens on a timeline. During the perimenopausal phase, ferritin and hepcidin levels rise sharply with age, while the increase mellows out after menopause is fully established.6PubMed Central. Changes in Iron Status Biomarkers with Advancing Age According to Sex and Menopause: A Population-Based Study At the same time, soluble transferrin receptor, a marker that goes up when your body is hungry for iron, drops as iron stores accumulate. In other words, your body goes from losing iron every month to stockpiling it.
Why does this matter practically? If you are 50 and still having periods, checking iron and ferritin makes sense to rule out deficiency. If your periods have recently stopped or become irregular, an iron panel helps establish where you are in that transition. And if you are fully postmenopausal, unexpectedly low iron warrants investigation since it could point to hidden blood loss from the gastrointestinal tract rather than the normal menstrual explanation. On the flip side, very high ferritin in a postmenopausal woman is usually benign and reflects the normal accumulation, but extremely elevated levels can signal inflammation or, rarely, iron overload conditions.
Vitamin B12
Vitamin B12 deficiency is an underdiagnosed and reversible cause of anemia and neurological symptoms in older adults.7PubMed Central. Vitamin B12 Deficiency Presenting as Anemia and Functional Decline in an Older Adult: A Case Report Testing is recommended when there are clinical signs, symptoms, or risk factors such as inadequate dietary intake or conditions that impair absorption.8PubMed Central. Vitamin B12 deficiency: testing and treatment At 50, the primary risk factor is reduced stomach acid. The most common cause of B12 deficiency in older adults is food-cobalamin malabsorption, which accounts for roughly 40 to 70 percent of cases and is driven mainly by atrophic gastritis, a condition where the stomach lining gradually thins and produces less acid.9Hong Kong Medical Journal. Vitamin B12 deficiency in the elderly: is it worth screening?
Without enough acid, B12 cannot be properly released from food for absorption. You can eat plenty of meat, eggs, and dairy and still become deficient if your stomach is not processing them properly. Long-term use of proton pump inhibitors (heartburn medications) and metformin (a common diabetes drug) also raises the risk. Symptoms of B12 deficiency include fatigue, weakness, numbness or tingling in the hands and feet, difficulty with balance, brain fog, and mood changes. These can creep in gradually and get chalked up to aging or stress.
A serum B12 level is the standard test, though it has known limitations. If your B12 is in the low-normal gray zone and you have symptoms, your doctor might also check methylmalonic acid, which is a more sensitive indicator of functional deficiency. The good news is that once identified, B12 deficiency responds well to supplementation, either oral or by injection depending on the underlying cause.
Cardiovascular Risk Markers Beyond the Lipid Panel
A standard lipid panel tells you your cholesterol numbers, but it does not capture the full picture of cardiovascular risk. Two additional blood markers are increasingly part of the conversation for women at 50, and they are worth understanding.
High-sensitivity C-reactive protein (hsCRP) measures low-grade inflammation in the body. Chronic inflammation damages blood vessel walls and drives the plaque buildup that leads to heart attacks and strokes. A large analysis found that the association between higher hsCRP and increased risk of major cardiovascular events, cardiovascular death, and all-cause death remained significant across subgroups defined by age, sex, BMI, diabetes status, blood pressure, smoking, kidney function, and cholesterol levels.10European Heart Journal. C-reactive protein and cardiovascular risk in the general population In plain terms, hsCRP adds information that your cholesterol numbers alone do not provide. It is particularly useful for women in an intermediate risk zone, where the lipid panel alone does not clearly point toward or away from treatment.
Lipoprotein(a), often written as Lp(a), is a genetically determined particle that raises cardiovascular risk independently of LDL cholesterol. Current cardiovascular guidelines incorporate Lp(a) as a “risk-enhancing factor” that helps personalize risk assessment beyond what standard scoring captures.11PubMed Central. Lipoprotein(a) in Personalized Cardiovascular Prevention: Risk Stratification, Coronary Artery Calcium, and Emerging Lp(a)-Lowering Therapies Because Lp(a) levels are largely set by your genes and stay fairly stable across your lifetime, you only need to check it once. If it comes back elevated, your doctor knows that your inherited cardiovascular risk is higher than your standard lipid numbers suggest, which can influence decisions about cholesterol-lowering medication and lifestyle intensity. Many women have never had Lp(a) measured; 50 is a reasonable time to get a baseline reading.
Do You Need Hormone Tests?
Women around 50 often wonder whether they should have estrogen, progesterone, or follicle-stimulating hormone (FSH) levels checked. The answer is: usually not, unless there is a specific clinical question to answer. Menopause is diagnosed by symptoms and menstrual history, not by a blood test. FSH levels fluctuate widely during perimenopause, so a single reading can be misleading. FSH does begin rising roughly six years before the final menstrual period and reaches levels nearly 14 times higher than what is seen in men, but that trajectory is gradual and irregular.12PubMed Central. Follicle-stimulating hormone: More than a marker for menopause: FSH as a frontier for women’s mental health
There are situations where FSH testing is genuinely helpful. If you had a hysterectomy (removal of the uterus) but still have your ovaries, you have no menstrual periods to track, so FSH can help determine whether you have reached menopause. It can also be useful for women who are much younger than the typical menopausal age and experiencing symptoms. But for most 50-year-old women with recognizable perimenopausal symptoms like irregular periods, hot flashes, and sleep disruption, FSH testing rarely changes what your doctor recommends. Estrogen and progesterone levels are even less useful as routine screens; they vary throughout the menstrual cycle and do not guide treatment decisions in the way many women assume they will.
Cortisol, sometimes marketed as part of “hormone panels” by direct-to-consumer lab companies, is another test that rarely makes sense as a routine screen. Cortisol concentrations fluctuate with time of day, stress, medications, and how the sample is collected, making a single blood draw unreliable for meaningful interpretation.13PubMed Central. Advances in salivary cortisol monitoring for healthcare applications Your doctor would order cortisol testing only if there is clinical suspicion of a specific adrenal condition, not as part of a general wellness panel.
What Routine Checkups Can and Cannot Do
There is an understandable impulse to run every blood test available on the assumption that catching something early is always better. The evidence on that is more nuanced. A review of research on general health checks in adult primary care found that periodic checkups were not associated with reduced mortality, cardiovascular events, or cardiovascular disease incidence. In one large study, adults invited to health checks saw no mortality benefit over eight years compared to adults who were not screened.14PubMed. General Health Checks in Adult Primary Care: A Review
That does not mean blood tests at 50 are pointless. The same review found that health checks did lead to increased detection of chronic conditions like hypertension and depression, better control of risk factors like blood pressure and cholesterol, and higher uptake of preventive screenings like colorectal and cervical cancer checks.14PubMed. General Health Checks in Adult Primary Care: A Review The takeaway is that targeted blood tests at 50, ordered with a reason and interpreted in context, are valuable. The diminishing returns come from blanket testing without a clinical rationale. Ordering a test you do not need can lead to false positives, unnecessary follow-up procedures, anxiety, and sometimes even treatment for conditions you never had.
For young, healthy, asymptomatic people, evidence-based guidelines have found no proven value in general blood tests for early disease detection, and such tests have occasionally been found to cause harm.15PubMed Central. Perspective of healthy asymptomatic patients requesting general blood tests from their physicians: a qualitative study But a 50-year-old woman is not in that category. Age 50 is the threshold where cardiovascular risk, metabolic changes, bone loss, and nutrient deficiencies all become common enough that screening has a genuine yield. The trick is knowing which tests have evidence behind them and which are just adding noise.
Tests You Might Need to Ask For
Standard “annual bloodwork” varies enormously from one doctor’s office to another. Some providers order a comprehensive set; others stick to the bare minimum of a CBC and metabolic panel. At 50, it is worth being proactive about making sure certain tests are included. Here is a practical list of tests that have good evidence behind them but are not always ordered automatically:
- Vitamin D: Not part of most standard panels. Ask for a 25-hydroxyvitamin D level, especially if you have risk factors like limited sun exposure, darker skin, or a family history of osteoporosis.
- TSH: Often included in annual labs, but not always. Given that thyroid dysfunction mimics perimenopause and affects roughly one in ten women in this age range, request it if it is not on your order.
- Vitamin B12: Not routinely checked unless you have symptoms or risk factors. Worth requesting if you take a proton pump inhibitor, metformin, follow a vegetarian or vegan diet, or have had stomach or intestinal surgery.
- Lp(a): Rarely included in standard lipid panels. A one-time measurement can reveal inherited cardiovascular risk that LDL alone would miss.
- hsCRP: Not part of a basic lipid panel. Useful if your doctor is trying to decide whether your cardiovascular risk justifies medication or more aggressive prevention.
- Iron panel with ferritin: Often skipped once heavy periods are no longer a concern. Still useful around menopause to understand where you are in the iron transition and to flag any unexpected deficiency.
- A1c: Sometimes included, sometimes not. Should be part of routine screening from 45 onward for all adults, per most diabetes screening guidelines.
If you are getting bloodwork done anyway, adding these tests to the order is straightforward. The conversation with your doctor does not need to be adversarial; most providers are happy to expand the panel when there is a clinical rationale. Coming in knowing which tests you want and why usually makes that conversation easier.
When Results Land in the Gray Zone
One of the most frustrating experiences at any age is getting results that fall in a borderline range. Your TSH is at the high end of normal but not flagged as abnormal. Your vitamin D is 25 ng/mL, above the deficiency cutoff of 20 but below the 30 that many experts consider sufficient. Your A1c is 5.8, technically prediabetic but not diabetic. What do you do?
Context matters more than the number itself. A borderline TSH in a woman with fatigue, dry skin, and weight gain tells a different story than the same number in someone who feels fine. A vitamin D of 25 in a woman with a family history of osteoporosis has different implications than a 25 in someone with strong bones and no risk factors. Your doctor should be interpreting these results against your symptoms, your history, and your other lab values, not just printing a sheet with numbers highlighted in yellow.
For lipids, borderline results are where the additional markers earn their keep. An LDL of 130 with a low hsCRP and a normal Lp(a) in an otherwise healthy woman is a very different picture from an LDL of 130 with elevated hsCRP and high Lp(a). The first scenario might warrant lifestyle changes and monitoring; the second could push the decision toward statin therapy. These are the kinds of distinctions that a basic panel alone cannot make, and they are exactly why requesting the extended markers is worthwhile at 50.
If you get borderline results and your doctor’s response is “let’s recheck in a year,” that is often reasonable. Many of these markers fluctuate, and a single reading does not define your health. What matters is tracking the trend. A vitamin D that has been creeping down over two years tells you more than one snapshot. An A1c that was 5.6 two years ago and is now 5.8 suggests a trajectory worth addressing now rather than waiting for it to cross the diabetes threshold.
Tests That Sound Useful but Are Not Standard
Direct-to-consumer lab companies and wellness influencers promote panels that go far beyond what evidence supports. Full thyroid panels with reverse T3, comprehensive sex hormone panels with estradiol and DHEA-S, food sensitivity IgG panels, heavy metal screens, and “inflammation panels” with dozens of cytokines are commonly marketed as essential. Most of these have no established value for asymptomatic screening in a 50-year-old woman.
Reverse T3, for instance, is used in specific clinical scenarios like critical illness, but it has no validated role in routine thyroid screening. DHEA-S is a real hormone that declines with age, but checking it without symptoms of adrenal dysfunction is unlikely to change your treatment. Food sensitivity IgG panels are not endorsed by any major allergy or immunology organization for diagnosing food intolerances. The appeal of these tests is understandable, and the companies selling them are very good at marketing them as proactive health measures. The reality is that ordering tests without a clear clinical question often generates ambiguous results that lead to unnecessary worry and spending.
The tests that genuinely matter at 50 are not exotic. They are the ones covered in this article: well-established markers for the specific health shifts that happen around menopause. If you have the budget and desire for additional testing, a better investment is usually ensuring that the core tests are done properly and interpreted thoughtfully, rather than layering on boutique panels that lack evidence for routine use.